The global epilepsy drugs market was valued at USD 10 billion in 2022 and grew at a CAGR of 4% from 2023 to 2032. The market is expected to reach USD 14.80 billion by 2032. The increasing prevalence of epilepsy will drive the growth of the global epilepsy drugs market.
El contenido subido será trasladado a este nuevo álbum. Debes crear una cuenta o entrar si quieres editar este álbum más adelante.